DATA DRIVEN DECISIONS

Interim Nonclinical
Study Monitoring

Make data-driven decisions while your study is ongoing. Real-time integration of disparate study data and analytics on Xbiom™ Insights.

Real-Time Data Integration

Study Reports published after completion offer little opportunity for on-study decisions. Xbiom™ enables you to identify toxicity signals early, adapt protocols, and consider new trial designs by monitoring interim data loaded as often as twice-daily.

Our solution aggregates and integrates disparate LIMS and Assay data from multiple sources, making it available to sponsor toxicologists in near-real-time.

Empowered Decisions

The Study Monitor is empowered to decide with agile aggregation of data from multiple sources.

Data Concierge Service

The Xbiom™ Advantage

Delivered on a private, encrypted, cloud-based environment for secure, authorized access.

🗄️

Data Concierge

A virtual team of data scientists and statisticians collecting and loading cytokines, bioanalytic, OMICs, and other data.

☁️

Any Data Source

Integrates disparate LIMS and Assay data. Accommodates all in-vivo studies including Transgenic, Xenograft, or Animal Rule models.

📈

Intuitive Analysis

Analyze data in any way you wish, with any grouping or cohorts, on a powerful and intuitive data platform.

🛡️

Consistency Check

Final datasets can be cross-checked against the interim set, assuring data consistency and minimal data gaps.

📊

Cost Savings

SEND datasets with nSDRG and Define.xml can be generated from this integrated data at 50% of the indicative SEND cost.

🔬

Expert Consults

For small BioTechs, we also offer board certified toxicologists for consults.

Minimize Surprises & Data Gaps

Periodic analysis and visualization while monitoring your study means fewer surprises when the final dataset is prepared.